When markets soar, fear sets in. But ditching a regular investing strategy at the top could sabotage long-term success.

Elston’s Bruce Williams discuss ResMed's results and margin momentum, and whether the stock still deserves a buy rating.

Not sure where to start this ASX FY25 reporting season? NAOS analyses keywords in earnings call transcripts to reveal the ...

Everyone hates the idea of losing money on shares, but can the fear hold you back from a lifetime of financial optimisation?

Stock price swings on earnings day have nearly doubled in 20 years as markets price information instantly, eliminating gradual adjustments.

The Fed should cut rates given consumer spending has stalled and core inflation is tracking slightly below its forecast profile.

This model has tracked the fair value of three-year yields quite reliably since 1990, is not overfitted and remains stable enough for out-of-sample forecasting. Currently, it suggests that bond yields ...

Trump’s tariff backdown hit the price but supply-demand themes remain strong; Sunstone among potential targets; ETM's Spanish acquisition.

Reporting season is stressful, but it also serves as a reminder of the importance of stepping back to reflect on broader themes shaping the world around us. One topic increasingly dominating ...

Wilson AM’s Damien Boey explains how the WAM Income Maximiser blends equity and debt to deliver flexible, inflation-aware ...